Faculty Opinions recommendation of Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
2011 ◽
Vol 29
(10)
◽
pp. e283-e284
◽
2011 ◽
Vol 50
(1)
◽
pp. 194-195
◽
2013 ◽
Vol 12
(11)
◽
pp. 2541-2558
◽
2007 ◽
Vol 13
(8)
◽
pp. 2512-2518
◽
2002 ◽
Vol 29
(5 Suppl 14)
◽
pp. 18-30
◽
2007 ◽
Vol 25
(16)
◽
pp. 2152-2155
◽